Bissen-Miyajima, Hiroko http://orcid.org/0000-0003-0417-2363
Ota, Yuka
Taira, Yoko
Takemura, Ryo
Minami, Keiichiro http://orcid.org/0000-0002-9799-8342
Funding for this research was provided by:
Johnson and Johnson
Article History
Received: 22 June 2023
Accepted: 22 August 2023
First Online: 11 September 2023
Declarations
:
: Hiroko Bissen-Miyajima reports grant, consultant, and speaker honorarium from Alcon and Johnson & Johnson Surgical Vision, consultant from BVI and Zeiss, speaker honorarium from BVI and Hoya. Yuka Ota reports speaker honorarium from Johnson & Johnson Surgical Vision. Keiichiro Minami reports Patent pending from Tomey. Yoko Taira and Ryo Takemura declare that they have no competing interests.
: This investigator-initiated study was approved by the Certified Review Board, Hattori Clinic and registered in the Japan Registry for Clinical Research (identifier: jRCTs032200218). The study was conducted in accordance with the tenets of the Declaration of Helsinki and the Clinical Trials Act of Japan (Act No. 16, 2017).